AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2019
Sep 10, 2019
30786_dirs_2019-09-09_d9c347d1-e0d2-49db-9391-90b7db33702e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-09-05
Reporting Person: HUTTON RONALD W (Vice President and Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-09-05 | Bio-Rad A Common Stock | M | 180 | — | Acquired | 4322.9448 | Direct |
| 2019-09-05 | Bio-Rad A Common Stock | F | 63 | $339.48 | Disposed | 4259.9448 | Direct |
| 2019-09-07 | Bio-Rad A Common Stock | M | 170 | — | Acquired | 4429.9448 | Direct |
| 2019-09-07 | Bio-Rad A Common Stock | F | 59 | $335.59 | Disposed | 4370.9448 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-09-05 | Restricted Stock Units | $0 | M | 180 | Disposed | Bio-Rad A Common Stock (180) | Direct | |
| 2019-09-07 | Restricted Stock Units | $0 | M | 170 | Disposed | Bio-Rad A Common Stock (170) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest in five equal annual installments beginning September 5, 2018.
F4: The restricted stock units vest in five equal annual installments beginning September 7, 2017.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13